Memory impairment in the D2. mdx mouse model of Duchenne muscular dystrophy is prevented by the adiponectin receptor agonist ALY688
Experimental Physiology · 2023-09 · 108 (9) · 1108-1117
DOI: 10.1113/ep091274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Physiology, online erschienen am 06.07.2023. Verfasst von Catherine A Bellissimo und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Kinesiology & Health Science, York University, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Canada Foundation for Innovation.
Abstract (Originalsprache)
Memory impairments have been well documented in people with Duchenne muscular dystrophy (DMD). However, the underlying mechanisms are poorly understood, and there is an unmet need to develop new therapies to treat this condition. Using a novel object recognition test, we show that recognition memory impairments in D2. mdx mice are completely prevented by daily treatment with the new adiponectin receptor agonist ALY688 from day 7 to 28 of age. In comparison to age‐matched wild‐type mice, untreated D2. mdx mice demonstrated lower hippocampal mitochondrial respiration (carbohydrate substrate), greater serum interleukin‐6 cytokine content and greater hippocampal total tau and Raptor protein contents. Each of these measures was partly or fully preserved after treatment with ALY688. Collectively, these results indicate that adiponectin receptor agonism improves recognition memory in young D2. mdx mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Kinesiology & Health Science, York University, Toronto, ON, Canada.
- Muscle Health Research Centre, York University, Toronto, Canada.
- Department of Health Sciences, Brock University, St Catharines, ON, Canada.
- Department of Biology, York University, Toronto, Ontario, Canada.
ORCID-Profile: Catherine A Bellissimo, Christopher G R Perry
Förderung
- Natural Sciences and Engineering Research Council of Canada
- Canada Foundation for Innovation
Zitieren
APA
Bellissimo, C. A., Castellani, L. N., Finch, M. S., Murugathasan, M., Gandhi, S., Sweeney, G., Abdul-Sater, A. A., MacPherson, R. E. K., & Perry, C. G. R. (2023). Memory impairment in the D2. mdx mouse model of Duchenne muscular dystrophy is prevented by the adiponectin receptor agonist ALY688. Experimental Physiology, 108(9), 1108-1117. https://doi.org/10.1113/ep091274
Vancouver
Bellissimo CA, Castellani LN, Finch MS, Murugathasan M, Gandhi S, Sweeney G, et al. Memory impairment in the D2. mdx mouse model of Duchenne muscular dystrophy is prevented by the adiponectin receptor agonist ALY688. Experimental Physiology. 2023;108(9):1108-1117. doi:10.1113/ep091274
BibTeX
@article{Bellissimo2023,
author = {Bellissimo, Catherine A and Castellani, Laura N and Finch, Michael S and Murugathasan, Mayoorey and Gandhi, Shivam and Sweeney, Gary and Abdul-Sater, Ali A and MacPherson, Rebecca E K and Perry, Christopher G R},
title = {Memory impairment in the D2. mdx mouse model of Duchenne muscular dystrophy is prevented by the adiponectin receptor agonist ALY688},
journal = {Experimental Physiology},
year = {2023},
volume = {108},
number = {9},
pages = {1108--1117},
doi = {10.1113/ep091274}
}
EUVIMED